Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs Enanta Pharmaceuticals
Over the past year ARCT returned +22.0% and ENTA returned +11.4%; their daily moves had a correlation of 0.27.
ARCT +22.0% ENTA +11.4%Growth of $1, one year, split-adjusted
| Metric | ARCT | ENTA |
|---|---|---|
| Price | $12.05 | $11.66 |
| Market cap | $342.5M | $339.6M |
| Today | +7.30% | −4.27% |
| 1 month | −12.0% | −7.8% |
| 6 months | +43.5% | −15.9% |
| Year to date | +96.6% | −26.1% |
| 1 year | +13.8% | +11.0% |
| Revenue growth (YoY) | −89.5% | −21.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −803.8% | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | 11.7× | 5.2× |
| Net cash | $191.5M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 113.0% | 44.4% |
| Short % of float | 19.2% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).